H.R. 4825 · 115th Congress

Marijuana Effective Drug Studies Act of 2018

Stage
In committee
Sponsor
Rob Bishop
Introduced
2018-01-18
Latest action
2018-01-24 · Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.

Summary

Marijuana Effective Drug Studies Act of 2018 or the MEDS Act

This bill amends the Controlled Substances Act to establish a new, separate registration process to facilitate research involving marijuana and the commercial production of drugs made from marijuana.

Specifically, the bill requires the Drug Enforcement Administration to register manufacturers and distributors to supply marijuana: (1) for use in research, and (2) for the commercial production of approved drugs containing or derived from marijuana.